UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by BB&T Corp

BB&T Corp cut its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 3.0% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 223,626 shares of the healthcare conglomerate’s stock after selling 6,948 shares during the period. UnitedHealth Group comprises 0.8% of BB&T Corp’s holdings, making the stock its 19th largest position. BB&T Corp’s holdings in UnitedHealth Group were worth $41,464,000 at the end of the most recent quarter.

A number of other large investors also recently added to or reduced their stakes in UNH. Macquarie Group Ltd. boosted its position in UnitedHealth Group by 5.4% in the fourth quarter. Macquarie Group Ltd. now owns 411,684 shares of the healthcare conglomerate’s stock valued at $65,886,000 after buying an additional 21,061 shares in the last quarter. Wsfs Capital Management LLC acquired a new position in UnitedHealth Group during the fourth quarter valued at $1,728,000. Searle & CO. acquired a new position in UnitedHealth Group during the fourth quarter valued at $537,000. Kentucky Retirement Systems Insurance Trust Fund acquired a new position in UnitedHealth Group during the fourth quarter valued at $4,932,000. Finally, Kentucky Retirement Systems acquired a new position in UnitedHealth Group during the fourth quarter valued at $11,054,000. 86.21% of the stock is currently owned by institutional investors and hedge funds.

UnitedHealth Group Incorporated (UNH) opened at 190.82 on Friday. UnitedHealth Group Incorporated has a 1-year low of $132.39 and a 1-year high of $196.04. The stock has a 50 day moving average price of $190.49 and a 200-day moving average price of $175.87. The company has a market cap of $184.50 billion, a price-to-earnings ratio of 22.92 and a beta of 0.64.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, July 18th. The healthcare conglomerate reported $2.46 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $2.38 by $0.08. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.32%. The company had revenue of $50.05 billion during the quarter, compared to analyst estimates of $49.97 billion. During the same period in the previous year, the business earned $1.96 EPS. UnitedHealth Group’s quarterly revenue was up 7.7% on a year-over-year basis. On average, equities research analysts forecast that UnitedHealth Group Incorporated will post $9.87 EPS for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 19th. Shareholders of record on Friday, September 8th will be paid a dividend of $0.75 per share. The ex-dividend date is Thursday, September 7th. This represents a $3.00 annualized dividend and a yield of 1.57%. UnitedHealth Group’s dividend payout ratio (DPR) is currently 35.13%.

TRADEMARK VIOLATION WARNING: “UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by BB&T Corp” was originally published by Community Financial News and is owned by of Community Financial News. If you are accessing this article on another domain, it was stolen and republished in violation of US & international copyright law. The correct version of this article can be viewed at https://www.com-unik.info/2017/08/19/bbt-corp-cuts-position-in-unitedhealth-group-incorporated-nyseunh-updated.html.

Several research analysts have recently weighed in on the company. Jefferies Group LLC restated a “buy” rating and issued a $192.00 price target on shares of UnitedHealth Group in a research note on Friday, May 19th. Cantor Fitzgerald restated an “overweight” rating and issued a $205.00 price target (up previously from $200.00) on shares of UnitedHealth Group in a research note on Saturday, April 22nd. Vetr cut UnitedHealth Group from a “buy” rating to a “hold” rating and set a $179.00 price objective for the company. in a research report on Monday, April 24th. Zacks Investment Research upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $201.00 price objective for the company in a research report on Wednesday, June 7th. Finally, Barclays PLC upped their price objective on UnitedHealth Group from $200.00 to $217.00 and gave the company an “overweight” rating in a research report on Wednesday, July 19th. One investment analyst has rated the stock with a hold rating and twenty-four have issued a buy rating to the company’s stock. The company has an average rating of “Buy” and an average price target of $203.41.

In other UnitedHealth Group news, Director William C. Ballard, Jr. sold 5,000 shares of the business’s stock in a transaction that occurred on Wednesday, June 7th. The stock was sold at an average price of $182.64, for a total transaction of $913,200.00. Following the completion of the sale, the director now directly owns 75,735 shares in the company, valued at approximately $13,832,240.40. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, Director Gail R. Wilensky sold 5,540 shares of the business’s stock in a transaction that occurred on Friday, June 2nd. The stock was sold at an average price of $178.74, for a total value of $990,219.60. Following the sale, the director now owns 60,516 shares of the company’s stock, valued at $10,816,629.84. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 15,540 shares of company stock valued at $2,873,320. 0.89% of the stock is owned by company insiders.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

What are top analysts saying about UnitedHealth Group Incorporated? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for UnitedHealth Group Incorporated and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit